Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease
2009; Oxford University Press; Volume: 25; Issue: 4 Linguagem: Inglês
10.1093/ndt/gfp592
ISSN1460-2385
AutoresSophie Liabeuf, Daniela V. Barreto, Fellype Carvalho Barreto, Natalie Meert, Griet Glorieux, Eva Schepers, M. Temmar, Gabriel Choukroun, Raymond Vanholder, Ziad A. Massy,
Tópico(s)Electrolyte and hormonal disorders
ResumoBackground. Uraemic toxins are considered to be emerging mortality risk factors in chronic kidney disease (CKD) patients. p-Cresol (a prototype protein-bound uraemic retention solute) has been shown to exert toxic effects in vitro. Recently, it has been demonstrated that p-cresol is present in plasma as its sulphate conjugate, p-cresylsulphate. The present study evaluated the distribution of free and total p-cresylsulphate and sought to determine whether these parameters were associated with vascular calcification, arterial stiffness and mortality risk in a cohort of CKD patients.
Referência(s)